Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial.
about
Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Rituximab versus cyclophospham ...... a randomised controlled trial.
@ast
Rituximab versus cyclophospham ...... a randomised controlled trial.
@en
type
label
Rituximab versus cyclophospham ...... a randomised controlled trial.
@ast
Rituximab versus cyclophospham ...... a randomised controlled trial.
@en
prefLabel
Rituximab versus cyclophospham ...... a randomised controlled trial.
@ast
Rituximab versus cyclophospham ...... a randomised controlled trial.
@en
P2093
P2860
P50
P1433
P1476
Rituximab versus cyclophospham ...... a randomised controlled trial
@en
P2093
Athol U Wells
Christopher P Denton
Daphne Babalis
Gregory J Keir
Helen Parfrey
Marcus D Flather
Vicky Tsipouri
P2860
P2888
P356
10.1186/S13063-017-2016-2
P577
2017-06-15T00:00:00Z
P6179
1086031227